*Alert to diabetologists* In this paper, we show that conventional ways (using clinical glucose cut-offs) is NOT enough The odds ratios will change depending on your cutoffs, and will miss important trends Classic risk assessment concepts! #epitwitter https://t.co/8PHEfT2wP7 https://t.co/gLDbLe0951
Fasting Blood Glucose and COVID-19 Severity: Nonlinearity Matters.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Oct 2020 – Feb 2023Where it's discussed
-
X / Twitter22 posts
-
Facebook2 posts
-
YouTube1 videos
AI synopsis
What people are saying
The discussions consistently highlight the critical finding that even small increases in fasting blood glucose substantially elevate COVID-19 severity risks, with examples like '36x ICU admission risk' and calls for 'strict glucose management,' illustrating a strong consensus on the study's potential to change clinical practices and improve patient outcomes.
All discussions strongly emphasize the importance of the study's findings, highlighting the link between elevated fasting blood glucose and increased COVID-19 severity, and echoing the call for stricter glucose management.
Participants show high interest, frequently mentioning the significant risk increase (up to 36x) and the nonlinear relationship found in the research, indicating engagement with the content's implications.
The comments reflect deep engagement through references to specific data points, such as the risk at 10 mmol/L and critiques of traditional risk assessment methods, demonstrating thoughtful analysis.
The discussions suggest the study could influence clinical practices, stressing that current cut-off strategies are insufficient and advocating for reevaluation of risk assessment techniques, which could significantly impact patient management.
Abstract in brief
- The study investigates how fasting blood glucose (FBG) levels relate to COVID-19 severity, especially the risk of ICU admission, using data from Kuwait.
- It compares traditional linear and categorical methods of modeling FBG with nonlinear approaches, finding that nonlinear models reveal more detailed relationships, such as a steep increase in risk with FBG levels up to around 10 mmol/L.
- The findings suggest that even small increases in FBG within the normal range can significantly raise the risk of severe COVID-19 outcomes, highlighting the importance of strict glucose control at hospital admission.]
Top posts
Most liked on X and BlueskyFasting Blood Glucose and COVID-19 Severity: Nonlinearity Matters Results argue for strict #glucose management on admission. Even a small increase within normal range of FBG may cause a substantial increase in risk of ICU admission for #COVID19 patients. https://t.co/t0AhmOvrKG https://t.co/huu3vJF7eY
Fasting Blood Glucose and COVID-19 Severity: Nonlinearity Matters https://t.co/3W5ChnAWOM
Fasting Blood Glucose and COVID-19 Severity: Nonlinearity Matters https://t.co/S3Fyr5FRRY
RT @Barrak1: *Alert to diabetologists* In this paper, we show that conventional ways (using clinical glucose cut-offs) is NOT enough The…
RT @ADA_Journals: Fasting Blood Glucose and COVID-19 Severity: Nonlinearity Matters Results argue for strict #glucose management on admiss…
All mentions
Diabetes and COVID-19: Fasting Blood Glucose's Impact on Severity
The study examines how fasting blood glucose levels relate to COVID-19 severity, revealing nonlinear relationships. Small increases in glucose can significantly elevate the risk of severe outcomes, emphasizing the…
RT @nicktg: @DrAseemMalhotra From August 2020. 36x ICU admission risk with elevated fasting blood glucose. https://t.co/5O6FTaRf7k https:…
@DrAseemMalhotra From August 2020. 36x ICU admission risk with elevated fasting blood glucose. https://t.co/5O6FTaRf7k https://t.co/aHt08tf0yf
How does hyperglycemia impact covid? 10 mmol/L vs. 5 mmol/L fasted blood glucose is 36x risk of ICU. https://t.co/5O6FTaRf7k
Fasting Blood Glucose and COVID-19 Severity: Nonlinearity Matters | Diabetes Care 10 mmol/L 36x more likely to end up in ICU compared to 5 mmol/L. Still can’t find anything on SSPG. https://t.co/4nH5SkuVBm
Fasting Blood Glucose and COVID-19 Severity: Nonlinearity Matters https://t.co/S3Fyr5FRRY
Fasting Blood Glucose and COVID-19 Severity: Nonlinearity Matters https://t.co/GtUYIfzlMF
Fasting Blood Glucose and COVID-19 Severity: Nonlinearity Matters https://t.co/vFsNijX4O9
Fasting Blood Glucose and COVID-19 Severity: Nonlinearity Matters https://t.co/OngSIXVUxn via @instapaper
RT @ADA_Journals: Fasting Blood Glucose and COVID-19 Severity: Nonlinearity Matters Results argue for strict #glucose management on admiss…
A small increase within a normal range of Fasting Blood Glucose has been linked to a higher risk of being admitted into the ICU for Covid https://t.co/itP84NWVeA #FMPH40Fall20
RT @ADA_Journals: Fasting Blood Glucose and COVID-19 Severity: Nonlinearity Matters Results argue for strict #glucose management on admiss…
RT @ADA_Journals: Fasting Blood Glucose and COVID-19 Severity: Nonlinearity Matters Results argue for strict #glucose management on admiss…
RT @ADA_Journals: Fasting Blood Glucose and COVID-19 Severity: Nonlinearity Matters Results argue for strict #glucose management on admiss…
RT @ADA_Journals: Fasting Blood Glucose and COVID-19 Severity: Nonlinearity Matters Results argue for strict #glucose management on admiss…
Fasting Blood Glucose and COVID-19 Severity: Nonlinearity Matters Results argue for strict #glucose management on admission. Even a small increase within normal range of FBG may cause a substantial increase in risk of ICU admission for #COVID19 patients. https://t.co/t0AhmOvrKG https://t.co/huu3vJF7eY
Fasting Blood Glucose and COVID-19 Severity: Nonlinearity Matters https://t.co/3W5ChnAWOM
RT @Barrak1: *Alert to diabetologists* In this paper, we show that conventional ways (using clinical glucose cut-offs) is NOT enough The…
RT @Barrak1: *Alert to diabetologists* In this paper, we show that conventional ways (using clinical glucose cut-offs) is NOT enough The…
RT @Barrak1: *Alert to diabetologists* In this paper, we show that conventional ways (using clinical glucose cut-offs) is NOT enough The…
RT @Barrak1: *Alert to diabetologists* In this paper, we show that conventional ways (using clinical glucose cut-offs) is NOT enough The…
RT @Barrak1: *Alert to diabetologists* In this paper, we show that conventional ways (using clinical glucose cut-offs) is NOT enough The…
*Alert to diabetologists* In this paper, we show that conventional ways (using clinical glucose cut-offs) is NOT enough The odds ratios will change depending on your cutoffs, and will miss important trends Classic risk assessment concepts! #epitwitter https://t.co/8PHEfT2wP7 https://t.co/gLDbLe0951
BA
AP
D糖
IS
حY
N
NG
M
JI
VA
RC
AS
Aا
F
MP
E